News & Updates

Show Multimedia Only

MRI better at predicting long-term structural damage in early RA

27 May 2025 by

In patients with early rheumatoid arthritis (RA), baseline MRI of the wrist is better than clinical, serological, or radiographic assessment at predicting long-term structural damage, an 8-year longitudinal study by researchers from the Chinese University of Hong Kong (CUHK) has shown.

MRI better at predicting long-term structural damage in early RA

27 May 2025

$Testosterone offers no long-distance mobility benefit to women with hip fracture$

Testosterone offers no long-distance mobility benefit to women with hip fracture

27 May 2025

Use of topical testosterone therapy in addition to supervised exercise training does little to improve long-distance walking ability for older women recovering from a hip fracture, according to the phase III STEP-HI randomized clinical trial.

Testosterone offers no long-distance mobility benefit to women with hip fracture

27 May 2025

Baricitinib compares favourably with filgotinib for RA

25 May 2025

In the treatment of patients with rheumatoid arthritis, baricitinib is equally effective as filgotinib at reducing disease activity, with similar drug retention rates, according to a retrospective study.

Baricitinib compares favourably with filgotinib for RA

25 May 2025

HF hospitalization risk greater in IMID patients

24 May 2025

Patients with immune-mediated inflammatory disease (IMID) are at increased risk of hospitalization for heart failure (HF) when compared to the general population, reveals a study.

HF hospitalization risk greater in IMID patients

24 May 2025

Adverse events push RA-ILD patients to discontinue nintedanib

23 May 2025

In patients with rheumatoid arthritis (RA)-related interstitial lung disease (ILD), combination therapy with disease-modifying antirheumatic drugs (DMARDs) does not negatively influence the safety and efficacy of nintedanib, reports a study. The main drivers of drug withdrawal or dose reduction in these individuals are adverse events (AEs), primarily due to comorbidities.

Adverse events push RA-ILD patients to discontinue nintedanib

23 May 2025

Some women in SG more inclined to undergo osteoporosis assessment, study finds

14 May 2025 by

In Singapore, sociodemographic and clinical factors as well as risk perception and health beliefs influence the willingness of perimenopausal and menopausal women to undergo Bone Mineral Densitometry for osteoporosis assessment, according to a study.

Some women in SG more inclined to undergo osteoporosis assessment, study finds

14 May 2025

Elevated thigh intramuscular fat infiltration ups risk of knee, hip osteoarthritis

10 May 2025

People with increased intramuscular fat infiltration (IMFI) in the thigh are at heightened risk of knee and hip osteoarthritis, according to a study.

Elevated thigh intramuscular fat infiltration ups risk of knee, hip osteoarthritis

10 May 2025

Inebilizumab helps prevent flare-ups in IgG4-related disease

07 May 2025

CD19-targeted B-cell depletion with inebilizumab appears to reduce the risk of flares and increase the likelihood of flare-free complete remission at 1 year in patients with IgG4-related disease, according to the phase III MITIGATE trial.

Inebilizumab helps prevent flare-ups in IgG4-related disease

07 May 2025

Hip OA outcomes do not significantly improve with add-on aerobic exercises

04 May 2025

In the management of hip osteoarthritis (OA), adding aerobic exercises to resistance training does not appear to substantially produce improvements in hip pain severity and function when compared with resistance exercises alone, according to the results of the PHOENIX study.

Hip OA outcomes do not significantly improve with add-on aerobic exercises

04 May 2025

Metformin shows knee OA pain-relieving potential

03 May 2025 by

Metformin, a common medication for diabetes, appears to produce a moderate reduction in knee pain and stiffness for overweight or obese individuals with symptomatic knee osteoarthritis (OA), as shown in the results of a randomized clinical trial.

Metformin shows knee OA pain-relieving potential

03 May 2025

News & Updates

Showing Rheumatology articles

Showing

Specialty:

MRI better at predicting long-term structural damage in early RA

MRI better at predicting long-term structural damage in early RA

Testosterone offers no long-distance mobility benefit to women with hip fracture

Testosterone offers no long-distance mobility benefit to women with hip fracture

Baricitinib compares favourably with filgotinib for RA

Baricitinib compares favourably with filgotinib for RA

HF hospitalization risk greater in IMID patients

HF hospitalization risk greater in IMID patients

Adverse events push RA-ILD patients to discontinue nintedanib

Adverse events push RA-ILD patients to discontinue nintedanib

Some women in SG more inclined to undergo osteoporosis assessment, study finds

Some women in SG more inclined to undergo osteoporosis assessment, study finds

Elevated thigh intramuscular fat infiltration ups risk of knee, hip osteoarthritis

Elevated thigh intramuscular fat infiltration ups risk of knee, hip osteoarthritis

Inebilizumab helps prevent flare-ups in IgG4-related disease

Inebilizumab helps prevent flare-ups in IgG4-related disease

Hip OA outcomes do not significantly improve with add-on aerobic exercises

Hip OA outcomes do not significantly improve with add-on aerobic exercises

Metformin shows knee OA pain-relieving potential

Metformin shows knee OA pain-relieving potential